"

From 2012.igem.org

Characterization of parts from Team Slovenia 2012

To test our chassis we decided to do a collaboration with a team working in vertebrate cells. After the Regional Jamboree, and the presentation of Team Slovenia during the final, we asked them to test one of their construction. Especially constructions using TAL activator constructs (basement of their switch system).

We received parts BBa_K782029 in the eukaryotic plasmid pCDNA3, and part BBa_K782065 in the eukaryotic plasmid pGL4.16.

The first plasmid possesses the part BBa_K782065 which contains the TAL A effector and the VP16 core under the control of the constitutive CMV promoter

The second plasmid possesses the part BBa_K782029 which contains 10 binding sites for TALA followed by the minimal promoter and the mCitrine reporter.

The TAL A system in Xenopus embryos

To test this system we first injected embryos with the plasmid BBa_K782029 which will express few mCitrine. In a second hand both plasmids,BBa_K782029 and BBa_K782065 were co-injected. The TALA VP16 expressed with the CMV promoter bind the 10x[A] sequence of the second plasmid and over-express mCitrine.